This included 75 cases of diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS), 22 cases of plasmablastic lymphoma, 3 cases of T-cell histiocyte-rich large B-cell lymphoma (TCHRBCL), 3 cases of high-grade B-cell lymphoma/DLBCL double-hit (MYC and BCL2), 1 case of high-grade B-cell lymphoma not otherwise specified (BCL NOS), 1 case of gray zone DLBCL, 1 case of Epstein-Barr virus-positive DLBCL, 1 case of primary mediastinal B-cell lymphoma (PMBL), and 1 case of follicular lymphoma grade 3B/follicular large B cell lymphoma [1]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.